Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA

Ann N Y Acad Sci. 1968 Jun 28;146(2):642-58. doi: 10.1111/j.1749-6632.1968.tb20322.x.
No abstract available

MeSH terms

  • Aminocaproates / administration & dosage
  • Aminocaproates / analysis
  • Aminocaproates / blood
  • Aminocaproates / pharmacology
  • Aminocaproates / therapeutic use*
  • Aminocaproates / urine
  • Animals
  • Antifibrinolytic Agents / administration & dosage
  • Antifibrinolytic Agents / analysis
  • Antifibrinolytic Agents / blood
  • Antifibrinolytic Agents / pharmacology
  • Antifibrinolytic Agents / therapeutic use
  • Antifibrinolytic Agents / urine
  • Cyclohexanecarboxylic Acids / therapeutic use*
  • Fibrinolysis / drug effects
  • Fibrinolytic Agents / pharmacology*
  • Heart / drug effects
  • Hematuria
  • Hemorrhage / drug therapy*
  • Humans
  • Swine

Substances

  • Aminocaproates
  • Antifibrinolytic Agents
  • Cyclohexanecarboxylic Acids
  • Fibrinolytic Agents